| Identification | Back Directory | [Name]
1H-Pyrazolo[3,4-g]quinoline, 4,4a,5,6,7,8,8a,9-octahydro-7-[(methylthio)methyl]-5-propyl-, (4aR,8aR)-rel- | [CAS]
374538-23-5 | [Synonyms]
Neuromuscular Disorder-Targeting Compound 1
1H-Pyrazolo[3,4-g]quinoline, 4,4a,5,6,7,8,8a,9-octahydro-7-[(methylthio)methyl]-5-propyl-, (4aR,8aR)-rel- | [Molecular Formula]
C15H25N3S | [MDL Number]
MFCD31544458 | [MOL File]
374538-23-5.mol | [Molecular Weight]
279.44 |
| Chemical Properties | Back Directory | [Boiling point ]
452.3±40.0 °C(Predicted) | [density ]
1.089±0.06 g/cm3(Predicted) | [storage temp. ]
Store at -20°C | [solubility ]
Soluble in DMSO | [pka]
15.32±0.40(Predicted) |
| Hazard Information | Back Directory | [Uses]
Neuromuscular Disorder-Targeting Compound 1 is used in the research of neuromuscular disorders such as symptoms of fibromyalgia syndrome and chronic fatigue syndrome. | [storage]
Store at -20°C | [References]
[1] Robertson, David W., et al. TREATMENT OF FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME. WO 2001087308 A1. |
|
| Company Name: |
MedChemExpress
|
| Tel: |
021-58955995 |
| Website: |
www.medchemexpress.com |
|